🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the manufacturers of acetaminophen, asserting the companies hid safety concerns that the pain reliever created to children's cognitive development.

This legal action comes four weeks after Former President Trump advocated an unverified association between using Tylenol - alternatively called paracetamol - throughout gestation and autism spectrum disorder in young ones.

Paxton is filing suit against the pharmaceutical giant, which once produced the medication, the exclusive pain medication approved for women during pregnancy, and the current manufacturer, which currently produces it.

In a official comment, he claimed they "betrayed America by making money from pain and promoting medication ignoring the risks."

The company asserts there is lacking scientific proof tying acetaminophen to autism spectrum disorder.

"These companies deceived for years, deliberately risking numerous people to increase profits," Paxton, from the Republican party, said.

The manufacturer commented that it was "very worried by the dissemination of inaccurate information on the safety of paracetamol and the possible consequences that could have on the well-being of women and children in America."

On its official site, Kenvue also said it had "continuously evaluated the applicable studies and there is no credible data that demonstrates a verified association between consuming paracetamol and autism."

Groups acting on behalf of medical professionals and health professionals share this view.

The leading OB-GYN organization has stated acetaminophen - the main ingredient in Tylenol - is among limited choices for women during pregnancy to address discomfort and fever, which can present significant medical dangers if not addressed.

"In over twenty years of research on the utilization of acetaminophen in gestation, no reliable research has successfully concluded that the consumption of acetaminophen in any trimester of gestation results in neurodevelopmental disorders in children," the association stated.

This legal action references current declarations from the previous government in claiming the medication is potentially dangerous.

Last month, the former president generated worry from public health officials when he instructed expectant mothers to "resist strongly" not to use Tylenol when ill.

The US Food and Drug Administration then issued a notice that medical professionals should contemplate reducing the consumption of Tylenol, while also stating that "a causal relationship" between the medication and autism spectrum disorder in children has not been established.

The Health Department head Robert F Kennedy Jr, who manages the FDA, had promised in April to initiate "comprehensive study program" that would establish the origin of autism spectrum disorder in a limited time.

But specialists warned that discovering a sole reason of autism spectrum disorder - thought by researchers to be the result of a complicated interplay of inherited and external influences - would prove challenging.

Autism spectrum disorder is a form of lifelong neurodivergence and impairment that impacts how persons perceive and engage with the world, and is recognized using doctors' observations.

In his court filing, the attorney general - aligned with the former president who is campaigning for federal office - alleges Kenvue and Johnson & Johnson "intentionally overlooked and tried to quiet the evidence" around acetaminophen and autism.

The case aims to force the companies "destroy any marketing or advertising" that asserts Tylenol is secure for pregnant women.

This legal action parallels the concerns of a group of parents of minors with autism spectrum disorder and ADHD who sued the producers of Tylenol in 2022.

The court dismissed the legal action, stating investigations from the parents' expert witnesses was lacking definitive proof.